These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 11083100)

  • 1. p53 tumor suppressor gene: at the crossroads of molecular carcinogenesis, molecular epidemiology, and human risk assessment.
    Hussain SP; Hollstein MH; Harris CC
    Ann N Y Acad Sci; 2000; 919():79-85. PubMed ID: 11083100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor suppressor genes: at the crossroads of molecular carcinogenesis, molecular epidemiology and human risk assessment.
    Hussain SP; Hofseth LJ; Harris CC
    Lung Cancer; 2001 Dec; 34 Suppl 2():S7-15. PubMed ID: 11720736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 tumor suppressor gene: at the crossroads of molecular carcinogenesis, molecular epidemiology, and cancer risk assessment.
    Harris CC
    Environ Health Perspect; 1996 May; 104 Suppl 3(Suppl 3):435-9. PubMed ID: 8781359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 mutation spectrum and load: the generation of hypotheses linking the exposure of endogenous or exogenous carcinogens to human cancer.
    Hussain SP; Harris CC
    Mutat Res; 1999 Jul; 428(1-2):23-32. PubMed ID: 10517975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TP53 mutation spectra and load: a tool for generating hypotheses on the etiology of cancer.
    Olivier M; Hussain SP; Caron de Fromentel C; Hainaut P; Harris CC
    IARC Sci Publ; 2004; (157):247-70. PubMed ID: 15055300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular epidemiology and carcinogenesis: endogenous and exogenous carcinogens.
    Hussain SP; Harris CC
    Mutat Res; 2000 Apr; 462(2-3):311-22. PubMed ID: 10767641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1995 Deichmann Lecture--p53 tumor suppressor gene: at the crossroads of molecular carcinogenesis, molecular epidemiology and cancer risk assessment.
    Harris CC
    Toxicol Lett; 1995 Dec; 82-83():1-7. PubMed ID: 8597035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 biological network: at the crossroads of the cellular-stress response pathway and molecular carcinogenesis.
    Hussain SP; Harris CC
    J Nippon Med Sch; 2006 Apr; 73(2):54-64. PubMed ID: 16641528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53: at the crossroads of molecular carcinogenesis and molecular epidemiology.
    Harris CC
    J Investig Dermatol Symp Proc; 1996 Apr; 1(2):115-8. PubMed ID: 9627703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular epidemiology of human cancer.
    Hussain SP; Harris CC
    Recent Results Cancer Res; 1998; 154():22-36. PubMed ID: 10026991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation and repair of DNA lesions in the p53 gene: relation to cancer mutations?
    Pfeifer GP; Denissenko MF
    Environ Mol Mutagen; 1998; 31(3):197-205. PubMed ID: 9585258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular epidemiology of human cancer.
    Hussain SP; Harris CC
    Toxicol Lett; 1998 Dec; 102-103():219-25. PubMed ID: 10022257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P53 gene alterations in human tumors: perspectives for cancer control.
    Hollstein M; Soussi T; Thomas G; von Brevern MC; Bartsch
    Recent Results Cancer Res; 1997; 143():369-89. PubMed ID: 8912433
    [No Abstract]   [Full Text] [Related]  

  • 14. Somatic mutations in human cancer: applications in molecular epidemiology.
    Le Roux E; Gormally E; Hainaut P
    Rev Epidemiol Sante Publique; 2005 Jun; 53(3):257-66. PubMed ID: 16227913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Environmental carcinogens and p53 gene mutation].
    Xu Z; Jin Y
    Wei Sheng Yan Jiu; 2004 Mar; 33(2):239-43. PubMed ID: 15209018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagenesis of the H-ras protooncogene and the p53 tumor suppressor gene.
    Cerutti P; Hussain P; Pourzand C; Aguilar F
    Cancer Res; 1994 Apr; 54(7 Suppl):1934s-1938s. PubMed ID: 7907948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The p53 tumour suppressor gene: a model for molecular epidemiology of human cancer.
    Soussi T
    Mol Med Today; 1996 Jan; 2(1):32-7. PubMed ID: 8796849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular epidemiology in cancer risk assessment and prevention: recent progress and avenues for future research.
    Wogan GN
    Environ Health Perspect; 1992 Nov; 98():167-78. PubMed ID: 1486846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mapping DNA damage to understand somatic mutagenesis].
    Lacoste S; Rochette PJ; Drouin R
    Med Sci (Paris); 2010 Feb; 26(2):193-200. PubMed ID: 20188052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 mutational spectra and the role of methylated CpG sequences.
    Pfeifer GP
    Mutat Res; 2000 May; 450(1-2):155-66. PubMed ID: 10838140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.